The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...
Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.
Novo Nordisk partners with Emcure to promote Wegovy, following Eli Lilly's recent collaboration with Cipla for tirzepatide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results